Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

ASH 2016: AML, CLL and leukaemogenesis latest

Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA
ASH 2016: AML, CLL and leukaemogenesis latest ( Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA )
5 Dec 2016

Advances in CLL from ASH 2016

Prof Stephan Stilgenbauer, Prof Clemens-Martin Wendtner, Prof Steven Coutre And Dr Jeffery Jones
Advances in CLL from ASH 2016 ( Prof Stephan Stilgenbauer, Prof Clemens-Martin Wendtner, Prof Steven Coutre And Dr Jeffery Jones )
5 Dec 2016

Ineligibility required for 'anti-trials': inclusion in studies regardless of fitness

Prof Guillermo Garcia-Manero - MD Anderson Cancer Center, Houston, USA
Ineligibility required for 'anti-trials': inclusion in studies regardless of fitness ( Prof Guillermo Garcia-Manero - MD Anderson Cancer Center, Houston, USA )
5 Dec 2016

Vosaroxin for relapsed AML: Updates from VALOR

Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA
Vosaroxin for relapsed AML: Updates from VALOR ( Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA )
5 Dec 2016

Impact of next-generation sequencing on treatment choice for MDS

Dr Ana Alfonso Pierola - MD Anderson Cancer Center, Houston, USA
Impact of next-generation sequencing on treatment choice for MDS ( Dr Ana Alfonso Pierola - MD Anderson Cancer Center, Houston, USA )
4 Dec 2016

Obinutuzumab extends PFS for follicular lymphoma in GALLIUM trial

Dr Andrew Davies - University of Southampton, Southampton, UK
Obinutuzumab extends PFS for follicular lymphoma in GALLIUM trial ( Dr Andrew Davies - University of Southampton, Southampton, UK )
4 Dec 2016

Venetoclax plus cytarabine in elderly AML patients

Dr Andrew Wei - Alfred Hospital, Melbourne, Australia
Venetoclax plus cytarabine in elderly AML patients ( Dr Andrew Wei - Alfred Hospital, Melbourne, Australia )
4 Dec 2016

Ibrutinib in CLL: RESONATE and resistance

Dr Jennifer Woyach - The Ohio State University Medical Center, Columbus, USA
Ibrutinib in CLL: RESONATE and resistance ( Dr Jennifer Woyach - The Ohio State University Medical Center, Columbus, USA )
4 Dec 2016

Durable remissions with the VcR-CVAD regimen for MCL regardless of age

Dr Julie Chang - University of Wisconsin Hospital and Clinics, Madison, USA
Durable remissions with the VcR-CVAD regimen for MCL regardless of age ( Dr Julie Chang - University of Wisconsin Hospital and Clinics, Madison, USA )
4 Dec 2016

TKI cessation for CML patients with deep molecular response: an update from the EURO-SKI trial

Dr Francois-Xavier Mahon - Université Bordeaux, Bordeaux, France
TKI cessation for CML patients with deep molecular response: an update from the EURO-SKI trial ( Dr Francois-Xavier Mahon - Université Bordeaux, Bordeaux, France )
3 Dec 2016

Dose reduction of TKIs for CML patients with deep molecular response

Prof Mhairi Copland - University of Glasgow, Glasgow, UK
Dose reduction of TKIs for CML patients with deep molecular response ( Prof Mhairi Copland - University of Glasgow, Glasgow, UK )
3 Dec 2016

Updates from the EURO-SKI trial of tyrosine kinase cessation

Dr Francois-Xavier Mahon - Université Bordeaux, Bordeaux, France
Updates from the EURO-SKI trial of tyrosine kinase cessation ( Dr Francois-Xavier Mahon - Université Bordeaux, Bordeaux, France )
3 Dec 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation